Vasopressin

Active pharmaceutical substance formulated in Jan Aushadhi generic products for Kidney & Urinary Care treatment.

🧴 Clinical Application

Administer intravenously as a continuous infusion (diluted in 0.9% NaCl or 5% Dextrose) via a central venous catheter: for septic shock, infuse 0.01 to 0.03 units/min. For esophageal variceal hemorrhage: infuse 0.2 to 0.4 units/min. Strictly for hospital ICU / critical care settings under continuous invasive hemodynamic monitoring.

⚠️ Side Effects

Common: Blanching of skin, abdominal colic, nausea, increased blood pressure. Rare/Severe: Myocardial ischemia, cardiac arrhythmias, mesenteric ischemia, digital necrosis, severe hyponatremia, and anaphylaxis.

🛡️ Safety Warnings

Black Box Caution: Potent vasoconstrictor; strictly contraindicated in coronary artery disease unless used in life-saving refractory vasodilatory shock. Administer via central line to prevent severe peripheral tissue necrosis and gangrene from extravasation. Monitor central venous pressure, ECG, and electrolytes continuously.